Pharmathen

Pharmathen is a research-centered pharmaceutical company that specializes in the development, manufacturing, and commercialization of complex drug delivery technologies, including long-acting injectables (LAI), sustained-release oral solids, and ophthalmic formulations. Founded in 1969, the company operates as a vertically integrated developer, owning its intellectual property and out-licensing it to a global network of over 250 customers across more than 90 countries. The company is recognized for its strong R&D capabilities and maintains multiple US FDA and EU-GMP certified manufacturing facilities, primarily in Greece. Pharmathen focuses on enhancing patient compliance through innovative drug delivery platforms and has recently expanded its investment in innovation hubs and production capacity to strengthen its competitive position in the international pharmaceutical market.